Our Team

We are led by an accomplished team with an exceptional track record of discovering, developing, and commercializing meaningful therapies for patients while creating value for stockholders. Our founding team has deep knowledge and significant experience in cGMP pathway research and development.

Andy Busch, PhD

Chief Scientific Officer

Mark Currie, PhD

Chair of Scientific Advisory Board

Christopher Wright, MD, PhD

Chief Medical Officer

Cheryl Gault

Chief Operating Officer

Peter Hecht, PhD

Chief Executive Officer

William Huyett

Strategic Advisor

Anjeza Gjino

Chief Financial Officer

Andy Busch, PhD

Chief Scientific Officer

Mark Currie, PhD

Chair of Scientific Advisory Board

Christopher Wright, MD, PhD

Chief Medical Officer

Cheryl Gault

Chief Operating Officer

Peter Hecht, PhD

Chief Executive Officer

William Huyett

Strategic Advisor

Anjeza Gjino

Chief Financial Officer

Board of Directors

Marsha Fanucci, Chair Peter Hecht, PhD Kevin Churchwell, MD George Conrades Ole Isacson, MD, PhD Stephanie Lovell Terrance McGuire Michael Mendelsohn, MD

Our Scientific Advisors

The women and men on our advisory boards bring diverse, global perspectives from basic science, clinical practice and industry to help us create better medicines for CNS disorders.

Andrew E. Budson, MD: Chief of Cognitive & Behavioral Neurology and Director of the Center for Translational Cognitive Neuroscience at the Veterans Affairs Boston Healthcare System, Associate Director and Education Leader of the Boston University Alzheimer’s Disease Research Center, Professor of Neurology at Boston University School of Medicine, and Lecturer in Neurology at Harvard Medical School 

Robert C. Malenka, MD, PhD: Pritzker Professor of Psychiatry and Behavioral Sciences, Director of the Nancy Pritzker Laboratory, and Deputy Director of the Wu Tsai Neurosciences Institute at Stanford University

David H. Salat, PhD: Director, Brain Aging and Dementia (BAnD) Laboratory, Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital; Associate Professor in Radiology at Harvard Medical School; and Director, Neuroimaging Research for Veterans (NeRVe) Center, Veterans Affairs (VA) Boston Healthcare System. 

Daniela Salvemini, PhD: Professor of Pharmacology and Physiology and Director of the Henry and Amelia Nasrallah Center for Neuroscience at St. Louis University

Harald H.H.W. Schmidt, MD, PhD, PharmD: Professor of Pharmacology and Chairman of the Department of Pharmacology and Personalized Medicine at Maastricht University

Eric Smith, MD: Professor of Neurology and the Katthy Taylor Chair in Vascular Dementia at the University of Calgary, Calgary Stroke Program

M Brandon Westover, MD, PhD: Physician Investigator in Neurology at Mass General Research Institute, Associate Professor of Neurology at Harvard Medical School, Associate Neurologist in Neurology at Massachusetts General Hospital, and Co-Founder, Beacon Biosignals

yellow-border

We are determined to create medicines that bring significant benefit to patients. We are committed to making a difference.

Top